Geisinger becomes VISTA’s first major clinical and life sciences partner

Voyager Technologies (NYSE:VOYG) has securedGeisinger, one of the largest integrated health systems in the United States, as a Voyager Institute for Space, Technology and Advancement (VISTA) partner. The memorandum of understanding (MOU) marks a significant expansion of VISTA’s reach into the life sciences and biopharma sector, establishing a framework for joint research programs that translate the unique conditions of microgravity into breakthrough pathways for human health.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.